Kevin Litchfield, MRC, The Francis Crick Institute, London, UK, discusses the emergence of immunotherapy, the considerations associated including toxicity, and future updates that are expected. Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.